Elizabeth D Ballard1, Dawn F Ionescu2, Jennifer L Vande Voort2, Elizabeth E Slonena2, Jose A Franco-Chaves3, Carlos A Zarate2, Christian Grillon4. 1. Experimental Therapeutics & Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: Elizabeth.Ballard@nih.gov. 2. Experimental Therapeutics & Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. 3. Department of Psychiatry, VA Caribbean Health Network, Veterans Health Administration, San Juan, Puerto Rico. 4. Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: Suicide is a common reason for psychiatric emergency and morbidity, with few effective treatments. Anxiety symptoms have emerged as potential modifiable risk factors in the time before a suicide attempt, but few studies have been conducted using laboratory measures of fear and anxiety. We operationally defined fear and anxiety as increased startle reactivity during anticipation of predictable (fear-potentiated startle) and unpredictable (anxiety-potentiated startle) shock. We hypothesized that a lifetime history of suicide attempt (as compared to history of no suicide attempt) would be associated with increased fear-potentiated startle. METHODS: A post-hoc analysis of fear- and anxiety-potentiated startle was conducted in 28 medication-free patients with Major Depressive Disorder (MDD) divided according to suicide attempt history. RESULTS: The magnitude of fear-potentiated startle was increased in depressed patients with lifetime suicide attempts compared to those without a lifetime history of suicide attempt (F(1,26)=5.629, p=.025). There was no difference in anxiety-potentiated startle by suicide attempt history. LIMITATIONS: This is a post-hoc analysis of previously analyzed patient data from a study of depressed inpatients. Further replication of the finding with a larger patient sample is indicated. CONCLUSIONS: Increased fear-potentiated startle in suicide attempters suggests the role of amygdala in depressed patients with a suicide attempt history. Findings highlight the importance of anxiety symptoms in the treatment of patients at increased suicide risk. Published by Elsevier B.V.
BACKGROUND: Suicide is a common reason for psychiatric emergency and morbidity, with few effective treatments. Anxiety symptoms have emerged as potential modifiable risk factors in the time before a suicide attempt, but few studies have been conducted using laboratory measures of fear and anxiety. We operationally defined fear and anxiety as increased startle reactivity during anticipation of predictable (fear-potentiated startle) and unpredictable (anxiety-potentiated startle) shock. We hypothesized that a lifetime history of suicide attempt (as compared to history of no suicide attempt) would be associated with increased fear-potentiated startle. METHODS: A post-hoc analysis of fear- and anxiety-potentiated startle was conducted in 28 medication-free patients with Major Depressive Disorder (MDD) divided according to suicide attempt history. RESULTS: The magnitude of fear-potentiated startle was increased in depressedpatients with lifetime suicide attempts compared to those without a lifetime history of suicide attempt (F(1,26)=5.629, p=.025). There was no difference in anxiety-potentiated startle by suicide attempt history. LIMITATIONS: This is a post-hoc analysis of previously analyzed patient data from a study of depressed inpatients. Further replication of the finding with a larger patient sample is indicated. CONCLUSIONS: Increased fear-potentiated startle in suicide attempters suggests the role of amygdala in depressedpatients with a suicide attempt history. Findings highlight the importance of anxiety symptoms in the treatment of patients at increased suicide risk. Published by Elsevier B.V.
Entities:
Keywords:
Fear-potentiated startle; Major depressive disorder; Suicide
Authors: Christian Grillon; Johanna M P Baas; Daniel S Pine; Shmuel Lissek; Megan Lawley; Valerie Ellis; Jessica Levine Journal: Biol Psychiatry Date: 2006-04-21 Impact factor: 13.382
Authors: Mark J Niciu; Daniel C Mathews; Allison C Nugent; Dawn F Ionescu; Maura L Furey; Erica M Richards; Rodrigo Machado-Vieira; Carlos A Zarate Journal: Depress Anxiety Date: 2013-12-18 Impact factor: 6.505
Authors: Jitender Sareen; Brian J Cox; Tracie O Afifi; Ron de Graaf; Gordon J G Asmundson; Margreet ten Have; Murray B Stein Journal: Arch Gen Psychiatry Date: 2005-11
Authors: Boris B Quednow; Jens Westheide; Kai-Uwe Kühn; Petra Werner; Wolfgang Maier; Barbara Hawellek; Michael Wagner Journal: J Affect Disord Date: 2006-02-28 Impact factor: 4.839
Authors: Elizabeth S Stevens; Lynne Lieberman; Carter J Funkhouser; Kelly A Correa; Stewart A Shankman Journal: Psychiatry Res Date: 2019-03-08 Impact factor: 3.222
Authors: Ricardo Cáceda; G Andrew James; Zachary N Stowe; Pedro L Delgado; Nolan Kordsmeier; Clint D Kilts Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-03-23 Impact factor: 5.270
Authors: Elizabeth D Ballard; Dawn F Ionescu; Jennifer L Vande Voort; Mark J Niciu; Erica M Richards; David A Luckenbaugh; Nancy E Brutsché; Rezvan Ameli; Maura L Furey; Carlos A Zarate Journal: J Psychiatr Res Date: 2014-08-12 Impact factor: 4.791
Authors: Liisa Hantsoo; Carla E M Golden; Sara Kornfield; Christian Grillon; C Neill Epperson Journal: Curr Psychiatry Rep Date: 2018-05-18 Impact factor: 5.285
Authors: Tiffany R Lago; Abigail Hsiung; Brooks P Leitner; Courtney J Duckworth; Kong Y Chen; Monique Ernst; Christian Grillon Journal: Depress Anxiety Date: 2018-04-10 Impact factor: 6.505